The Role of Inflammation in Brain and Cognitive Function in Mental Disorders

Trial Profile

The Role of Inflammation in Brain and Cognitive Function in Mental Disorders

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Aug 2017

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Schizoaffective disorder
  • Focus Therapeutic Use
  • Acronyms IRIS
  • Most Recent Events

    • 15 Aug 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 31 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top